Net profit of Strides Pharma Science rose 129.80% to Rs 202.11 crore in the quarter ended December 2025 as against Rs 87.95 crore during the previous quarter ended December 2024. Sales rose 3.55% to Rs 1194.65 crore in the quarter ended December 2025 as against Rs 1153.67 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 1194.65 | 1153.67 | 4 |
| OPM % | 19.75 | 18.23 | - |
| PBDT | 299.40 | 164.70 | 82 |
| PBT | 248.78 | 116.28 | 114 |
| NP | 202.11 | 87.95 | 130 |
Powered by Capital Market - Live News